ACADIA (ACAD) Upgraded to Buy After Recent Pullback
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc.
Posts Tagged ‘ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’
10 Most Profitable Biotech Stocks to Buy Now
Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, surpassing both the S&P 500 and the broader market index...
ACADIA Pharmaceuticals Inc. (ACAD) PT Trimmed Slightly as RBC Flags Seasonal Biotech Headwinds
TheFly reported on April 7 that RBC Capital Markets revised its outlook on ACAD, lowering its price target from $30 to $29 while keeping an Outperform rating.
9 Most Undervalued Healthcare Stocks to Buy Now
On April 17, Matt Powers, managing partner at Powers Advisory Group, appeared on CNBC’s Squawk Box to discuss the forces shaping current market behavior.
Wolfe Research Notes Conviction-Driven Opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) Therapeutic Domains
TheFly reported on February 23 that Wolfe Research initiated coverage of ACAD with an Outperform rating and a $33 price target.
10 Fastest Growing Mid Cap Stocks to Buy Now
The Federal Reserve’s pivot from higher interest rates to rate cuts is creating a meaningful shift for mid-cap stocks, according to Amy Y.
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. (ACAD) For 2026
TheFly reported on February 6 that Oppenheimer raised its price target on ACAD to $23 from $21 and maintained a Perform rating on the shares.
15 Innovative Healthcare Stocks to Buy According to Analysts
Over the last two years, artificial intelligence has propelled global financial markets into a boom, with stocks reaching all-time highs.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
11 Best Performing Long Term Stocks According to Analysts
On September 19, Alli McCartney, Managing Director at UBS Private Wealth Management, and Philip Straehl, CIO Americas at Morningstar Wealth, joined CNBC to the rate cuts, market...
ACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi Syndrome
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company that focuses on therapies for central nervous system disorders and rare diseases.
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company specializing in therapies for central nervous system disorders and rare diseases.
11 Cheap Biotech Stocks to Buy According to Hedge Funds
Mizuho's Jared Holz appeared on CNBC's "Closing Bell Overtime" on July 8 to talk about whether the biotech industry is prepared for a breakthrough.
Acadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top Talent
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is one of the 10 biotech stocks screaming a buy.
10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 13 Biotech Stocks with Huge Upside Potential. It declared that the U.S.
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
BofA Securities Lifts ACADIA Pharmaceuticals Inc. (ACAD)’s Price Target To $23, Maintains Neutral Rating
[caption id="attachment_1202489" align="aligncenter" width="1456"] A research scientist looking through a microscope in a lab, symbolizing the biopharmaceutical company's innovative...
Why ACADIA Pharmaceuticals Inc. (ACAD) Skyrocketed on Friday
We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
12 Best Nasdaq Stocks Under $20 to Buy Now
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
10 Worst-Performing Growth Stocks in 2024
Economists anticipate modest US economic growth in the upcoming quarters, and some continue to caution that a mild recession could occur.
7 Best Halal Stocks To Buy Now (Debt Free)
In this article, we will be taking a look at the 7 best halal stocks to buy now (debt free).
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Billionaire Steve Cohen and Insiders are Buying These 5 Stocks
This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire ...
5 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold biotech stocks to buy right now.
5 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold NASDAQ stocks to buy right now.
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts
In this article, we will take a look at the 10 stocks receiving a massive vote of approval from Wall Street analysts.
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
10 Trending Stocks to Watch Today
The US stock market is on the rise today as all the 11 major S&P Sectors are in the green.
5 Best Stocks To Buy For Beginners Right Now
In this article, we discuss 5 best stocks to buy for beginners right now.
10 Reddit Stocks that Flopped in 2021
In this article, we discuss the 10 Reddit stocks that flopped in 2021.
15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Analysts are Cutting Price Targets of These 10 Stocks
In this article, we discuss the 10 stocks that analysts are cutting price targets of.
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (NASDAQ:ACAD)
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week.
Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
Julian Baker and Felix Baker, the managers of Baker Bros.
Microsoft Corporation (MSFT), Bank of America Corp (BAC), ACADIA Pharmaceuticals Inc. (ACAD) Among Thursday Leaders
Editor's note: Related tickers: Microsoft Corporation (NASDAQ:MSFT), Bank of America Corp (NYSE:BAC), Research In Motion Ltd (NASDAQ:BBRY), ACADIA Pharmaceuticals Inc.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? – Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)
To most stock holders, hedge funds are perceived as worthless, old financial vehicles of years past.
Do Hedge Funds and Insiders Love Optimer Pharmaceuticals, Inc. (OPTR)? – ACADIA Pharmaceuticals Inc. (ACAD), Merrimack Pharmaceuticals Inc (MACK)
To most market participants, hedge funds are assumed to be slow, old financial vehicles of the past.
Should You Avoid EXACT Sciences Corporation (NASDAQ:EXAS)? – Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Array Biopharma Inc (NASDAQ:ARRY)
Is EXACT Sciences Corporation (NASDAQ:EXAS) ready to raly soon? Investors who are in the know are becoming less hopeful.
Hedge Fund Resource Center
